Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-28

FDA Approved: ABACAVIR — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Abacavir submitted by Cipla USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • abacavir (abacavir)

Snippet

SUPPL AP for ABACAVIR (ABACAVIR)